Tamoxifen Reduces Thromboembolism Risk in American Male Cancer Patients: A Retrospective Study
Reading Time: 2 minutesIntroduction Tamoxifen, a selective estrogen receptor modulator (SERM), has been widely recognized for its role in the treatment and prevention of hormone receptor-positive breast cancer. However, its application extends beyond oncology, particularly in the context of thromboembolic disease management. Recent studies have begun to explore the potential of tamoxifen in reducing the risk of thromboembolism among cancer patients, a group... Read more »
